Mono-sensitisation to peanut component Ara h 6: a case series of five children and literature review
- PMID: 27206507
- PMCID: PMC5005383
- DOI: 10.1007/s00431-016-2733-7
Mono-sensitisation to peanut component Ara h 6: a case series of five children and literature review
Abstract
Here, we summarise the current clinical knowledge on Ara h 6 sensitisation and clinical relevance of this sensitisation pattern using five illustrative clinical cases. The literature search yielded a total of 166 papers, and an additional relevant article was found by 'snowballing'. A total of ten articles were considered relevant for this review. Most studies included patients with a sensitisation to Ara h 6 and cosensitisation to Ara h 2. Only three studies showed patients with a mono-sensitisation to Ara h 6. This illustrates that Ara h 6 mono-sensitisation has been neglected in literature. We present a case series of five children with sensitisation to peanut component Ara h 6. Only one of these five patients showed Ara h 8 cosensitivity. Three out of the five children had a positive double-blind placebo-controlled food challenge (DBPCFC), with moderate to strong reactions.
Conclusion: A mono-sensitisation to peanut component Ara h 6 is uncommon but can cause severe allergic reactions. Therefore, the determination of sIgE to Ara h 6 is warranted in patients with a suspected peanut allergy, especially in the absence of sensitisation to Ara h 1, 2, 3 and 9.
What is known: • Peanut allergy is common and can cause severe allergic reactions. • The diagnostics of peanut allergy has recently improved with the use of component resolved diagnosis What is new: • A mono-sensitisation to peanut component Ara h 6 is uncommon, but can cause severe allergic reactions • Determination of sIgE to Ara h 6 is warranted in patients with a suspected peanut allergy, especially in the absence of sensitisation to Ara h 1, 2, 3 and 9.
Keywords: Ara h 6; Components; Double-blind placebo-controlled food challenge (DBPCFC); Peanut allergy.
Conflict of interest statement
Compliance with ethical standards This study was not funded. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Conflict of interest The authors declare that they have no conflict of interest.
Similar articles
-
Ara h 2 and Ara 6 are the best predictors of severe peanut allergy: a double-blind placebo-controlled study.Allergy. 2015 Oct;70(10):1239-45. doi: 10.1111/all.12671. Epub 2015 Jul 1. Allergy. 2015. PMID: 26095653 Clinical Trial.
-
Diagnostic accuracy of Ara h 2 for detecting peanut allergy in children.Clin Exp Allergy. 2021 Aug;51(8):1069-1079. doi: 10.1111/cea.13987. Epub 2021 Jul 29. Clin Exp Allergy. 2021. PMID: 34288182 Free PMC article.
-
Diagnostic Value of Antigen-Specific Immunoglobulin E Immunoassays against Ara h 2 and Ara h 8 Peanut Components in Child Food Allergy.Int Arch Allergy Immunol. 2016;169(4):216-22. doi: 10.1159/000446181. Epub 2016 May 26. Int Arch Allergy Immunol. 2016. PMID: 27225199
-
Accuracy of component-resolved diagnostics in peanut allergy: Systematic literature review and meta-analysis.Pediatr Allergy Immunol. 2020 Apr;31(3):303-314. doi: 10.1111/pai.13201. Epub 2020 Jan 28. Pediatr Allergy Immunol. 2020. PMID: 31872899
-
Serologic measurements for peanut allergy: Predicting clinical severity is complex.Ann Allergy Asthma Immunol. 2024 Jun;132(6):686-693. doi: 10.1016/j.anai.2024.01.018. Epub 2024 Jan 24. Ann Allergy Asthma Immunol. 2024. PMID: 38272114 Review.
Cited by
-
Real world use of peanut component testing among children in the Chicago metropolitan area.Allergy Asthma Proc. 2022 May 1;43(3):226-233. doi: 10.2500/aap.2022.43.220021. Allergy Asthma Proc. 2022. PMID: 35524355 Free PMC article.
-
Ara h 2 is the dominant peanut allergen despite similarities with Ara h 6.J Allergy Clin Immunol. 2020 Sep;146(3):621-630.e5. doi: 10.1016/j.jaci.2020.03.026. Epub 2020 Apr 13. J Allergy Clin Immunol. 2020. PMID: 32298698 Free PMC article.
-
Will Oral Food Challenges Still Be Part of Allergy Care in 10 Years' Time?J Allergy Clin Immunol Pract. 2023 Apr;11(4):988-996. doi: 10.1016/j.jaip.2023.02.010. Epub 2023 Feb 22. J Allergy Clin Immunol Pract. 2023. PMID: 36822320 Free PMC article. Review.
-
Peanut components measured by ISAC: comparison with ImmunoCap and clinical relevance in peanut allergic children.Clin Mol Allergy. 2021 Aug 9;19(1):14. doi: 10.1186/s12948-021-00153-w. Clin Mol Allergy. 2021. PMID: 34372856 Free PMC article.
-
Variable IgE cross-reactivity between peanut 2S-albumins: The case for measuring IgE to both Ara h 2 and Ara h 6.Clin Exp Allergy. 2019 Aug;49(8):1107-1115. doi: 10.1111/cea.13432. Epub 2019 Jun 5. Clin Exp Allergy. 2019. PMID: 31108010 Free PMC article. Clinical Trial.
References
-
- Ackerbauer D, Bublin M, Radauer C, Varga EM, Hafner C, Ebner C, Szepfalusi Z, Froschl R, Hoffmann-Sommergruber K, Eiwegger T, et al. Component-resolved IgE profiles in Austrian patients with a convincing history of peanut allergy. Int Arch Allergy Immunol. 2015;166:13–24. doi: 10.1159/000371422. - DOI - PubMed
-
- Agabriel C, Ghazouani O, Birnbaum J, Liabeuf V, Porri F, Gouitaa M, Cleach I, Grob JJ, Bongrand P, Sarles J, et al. Ara h 2 and Ara h 6 sensitization predicts peanut allergy in Mediterranean pediatric patients. Pediatr Allergy Immunol : Off Publ Eur Soc Pediatr Allergy Immunol. 2014 - PubMed
-
- Ballmer-Weber BK, Lidholm J, Fernandez-Rivas M, Seneviratne S, Hanschmann KM, Vogel L, Bures P, Fritsche P, Summers C, Knulst AC, et al. IgE recognition patterns in peanut allergy are age dependent: perspectives of the EuroPrevall study. Allergy. 2015;70:391–407. doi: 10.1111/all.12574. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources